Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $144,637 - $185,438
2,449 New
2,449 $181,000
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $811,384 - $1.22 Million
-17,194 Reduced 96.94%
542 $36,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $538,287 - $942,668
17,736 New
17,736 $878,000
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $196,982 - $273,547
-2,717 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$90.24 - $124.05 $634,748 - $872,567
-7,034 Reduced 72.14%
2,717 $259,000
Q2 2021

Aug 12, 2021

BUY
$93.66 - $139.27 $913,278 - $1.36 Million
9,751 New
9,751 $1.21 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $485,514 - $645,616
-4,165 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $414,875 - $591,929
4,165 New
4,165 $551,000
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $746,700 - $1.04 Million
-10,240 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $570,880 - $949,760
10,240 New
10,240 $890,000
Q4 2019

Feb 10, 2020

SELL
$77.66 - $99.74 $1.16 Million - $1.49 Million
-14,987 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $1.35 Million - $1.84 Million
14,987 New
14,987 $1.35 Million
Q3 2018

Nov 13, 2018

SELL
$48.29 - $80.6 $1.29 Million - $2.16 Million
-26,817 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$37.84 - $69.96 $887,423 - $1.64 Million
23,452 Added 696.94%
26,817 $1.6 Million
Q1 2018

May 11, 2018

BUY
$39.82 - $57.53 $133,994 - $193,588
3,365 New
3,365 $135,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.